Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Biology of the Cell|April 25, 2013
Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarraysSemjon Willier, Elke Butt, Thomas G P Grunewald
Journal of Hematology & Oncology|February 8, 2019
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantationTheresa Kaeuferle, Ramona Krauss, Franziska Blaeschke, et al.
Biology of the Cell|November 8, 2011
Defining the role of TRIP6 in cell physiology and cancerSemjon Willier, Elke Butt, Günther H S Richter, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 20, 2020
CRISPR-Cas9-Mediated Glucocorticoid Resistance in Virus-Specific T Cells for Adoptive T Cell Therapy PosttransplantationTheresa Kaeuferle, Larissa Deisenberger, Lena Jablonowski, et al.
Plos One|September 7, 2022
Generation of full-length circular RNA libraries for Oxford Nanopore long-read sequencingSteffen Fuchs, Loélia Babin, Elissa Andraos, et al.
BMC Cancer|November 16, 2019
Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation studySemjon Willier, Karin Melanie Cabanillas Stanchi, Martina von Have, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2018
Induction of a central memory and stem cell memory phenotype in functionally active CD4+ and CD8+ CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19+ acute lymphoblastic leukemiaFranziska Blaeschke, Dana Stenger, Theresa Kaeuferle, et al.
Frontiers in Immunology|April 25, 2022
Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell FunctionFranziska Blaeschke, Eva Ortner, Dana Stenger, et al.
Experimental Hematology & Oncology|March 20, 2025
All-in-one CRISPR/Cas-engineered glucocorticoid-receptor knock-out EBV-gp350-CAR knock-in T cells are potent and resistant to dexamethasoneTheresa Kaeuferle, Maximilian Zwermann, Nadine Stoll, et al.
Clinical & Translational Immunology|February 2, 2022
Genome-wide off-target analyses of CRISPR/Cas9-mediated T-cell receptor engineering in primary human T cellsTheresa Kaeuferle, Tanja A Stief, Stefan Canzar, et al.
Pageof 3